These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 29706955

  • 1. Antibody Repertoires Identify β-Tubulin as a Host Protective Parasite Antigen in Mice Infected With Trypanosoma cruzi.
    Montalvão F, Nascimento DO, Nunes MP, Koeller CM, Morrot A, Lery LMS, Bisch PM, Teixeira SMR, Vasconcellos R, Freire-de-Lima L, Lopes MF, Heise N, DosReis GA, Freire-de-Lima CG.
    Front Immunol; 2018; 9():671. PubMed ID: 29706955
    [Abstract] [Full Text] [Related]

  • 2. Heterologous Chimeric Construct Comprising a Modified Bacterial Superantigen and a Cruzipain Domain Confers Protection Against Trypanosoma cruzi Infection.
    Antonoglou MB, Sánchez Alberti A, Redolfi DM, Bivona AE, Fernández Lynch MJ, Noli Truant S, Sarratea MB, Iannantuono López LV, Malchiodi EL, Fernández MM.
    Front Immunol; 2020; 11():1279. PubMed ID: 32695105
    [Abstract] [Full Text] [Related]

  • 3. Fetal IgG specificities against Trypanosoma cruzi antigens in infected newborns.
    Reyes MB, Lorca M, Muñoz P, Frasch AC.
    Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2846-50. PubMed ID: 2108442
    [Abstract] [Full Text] [Related]

  • 4. Comparison between autoantibodies arising during Trypanosoma cruzi infection in mice and natural autoantibodies.
    Ternynck T, Bleux C, Gregoire J, Avrameas S, Kanellopoulos-Langevin C.
    J Immunol; 1990 Feb 15; 144(4):1504-11. PubMed ID: 2106000
    [Abstract] [Full Text] [Related]

  • 5. Comparison of antibody and protective immune responses against Trypanosoma cruzi infection elicited by immunization with a parasite antigen delivered as naked DNA or recombinant protein.
    Pereira-Chioccola VL, Costa F, Ribeirão M, Soares IS, Arena F, Schenkman S, Rodrigues MM.
    Parasite Immunol; 1999 Feb 15; 21(2):103-10. PubMed ID: 10101720
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of a trans-sialidase-ISCOMATRIX subunit vaccine candidate to protect against experimental Chagas disease.
    Bontempi IA, Vicco MH, Cabrera G, Villar SR, González FB, Roggero EA, Ameloot P, Callewaert N, Pérez AR, Marcipar IS.
    Vaccine; 2015 Mar 03; 33(10):1274-83. PubMed ID: 25625671
    [Abstract] [Full Text] [Related]

  • 7. Use of Tc-rCRP as a target for lytic antibody titration after experimental Trypanosoma cruzi infection.
    Marques T, Silva GC, Henrique Paiva PM, Nascentes GAN, Ramirez LE, Norris K, Meira WSF.
    Exp Parasitol; 2018 Jan 03; 184():103-108. PubMed ID: 29246832
    [Abstract] [Full Text] [Related]

  • 8. Trypanosoma cruzi: serum antibody reactivity to the parasite antigens in susceptible and resistant mice.
    de Gaspari EN, Umezawa ES, Zingales B, Stolf AM, Colli W, Abrahamsohn IA.
    Mem Inst Oswaldo Cruz; 1990 Jan 03; 85(3):261-70. PubMed ID: 2134701
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of immune responses raised against Tc13 antigens of Trypanosoma cruzi in the outcome of murine experimental infection.
    García GA, Arnaiz MR, Esteva MI, Laucella SA, Garavaglia PA, Ibarra SE, Ruiz AM.
    Parasitology; 2008 Mar 03; 135(3):347-57. PubMed ID: 17991305
    [Abstract] [Full Text] [Related]

  • 10. Trypanosoma cruzi: analysis of cellular and humoral response against a protective recombinant antigen during experimental Chagas' disease.
    Taibi A, Espinoza AG, Ouaissi A.
    Immunol Lett; 1995 Dec 03; 48(3):193-200. PubMed ID: 8867851
    [Abstract] [Full Text] [Related]

  • 11. Characterising the KMP-11 and HSP-70 recombinant antigens' humoral immune response profile in chagasic patients.
    Flechas ID, Cuellar A, Cucunubá ZM, Rosas F, Velasco V, Steindel M, Thomas Mdel C, López MC, González JM, Puerta CJ.
    BMC Infect Dis; 2009 Nov 25; 9():186. PubMed ID: 19939275
    [Abstract] [Full Text] [Related]

  • 12. IgG antibody reactivity with Trypanosoma cruzi and Leishmania antigens in sera of patients with Chagas' disease and leishmaniasis.
    Chiller TM, Samudio MA, Zoulek G.
    Am J Trop Med Hyg; 1990 Dec 25; 43(6):650-6. PubMed ID: 2125177
    [Abstract] [Full Text] [Related]

  • 13. Experimental evidences that P21 protein controls Trypanosoma cruzi replication and modulates the pathogenesis of infection.
    Teixeira TL, Castilhos P, Rodrigues CC, da Silva AA, Brígido RT, Teixeira SC, Borges BC, Dos Santos MA, Martins FA, Santos PCF, Servato JPS, Silva MS, da Silva MJB, Elias MC, da Silva CV.
    Microb Pathog; 2019 Oct 25; 135():103618. PubMed ID: 31310832
    [Abstract] [Full Text] [Related]

  • 14. Previously unrecognized vaccine candidates control Trypanosoma cruzi infection and immunopathology in mice.
    Bhatia V, Garg NJ.
    Clin Vaccine Immunol; 2008 Aug 25; 15(8):1158-64. PubMed ID: 18550728
    [Abstract] [Full Text] [Related]

  • 15. Trypanosoma cruzi tubulin eliminated in the urine of the infected host.
    Bertot GM, Corral RS, Fresno M, Rodríguez C, Katzin AM, Grinstein S.
    J Parasitol; 1998 Jun 25; 84(3):608-14. PubMed ID: 9645865
    [Abstract] [Full Text] [Related]

  • 16. [The diagnosis of chronic Chagas disease using recombinant antigens of Trypanosoma cruzi].
    Lorca M, González A, Reyes V, Veloso C, Vergara U, Frasch C.
    Rev Med Chil; 1993 Apr 25; 121(4):363-8. PubMed ID: 8272605
    [Abstract] [Full Text] [Related]

  • 17. IgG subclasses responsible for immune clearance in mice infected with Trypanosoma cruzi.
    Brodskyn CI, Silva AM, Takehara HA, Mota I.
    Immunol Cell Biol; 1989 Dec 25; 67 ( Pt 6)():343-8. PubMed ID: 2516504
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of pathogen P21 protein as a potential modulator of the protective immunity induced by Trypanosoma cruzi attenuated parasites.
    Pérez Brandán C, Mesias AC, Acuña L, Teixeira TL, da Silva CV.
    Mem Inst Oswaldo Cruz; 2019 Dec 25; 114():e180571. PubMed ID: 31116244
    [Abstract] [Full Text] [Related]

  • 19. Trypanosoma cruzi exoantigens: can those recognized by sera from chagasic patients trigger a protective immune response in mice?
    Gruppi A, Pistoresi-Palencia MC, Cerban F, Vottero-Cima E.
    Res Immunol; 1991 Dec 25; 142(9):821-8. PubMed ID: 1796212
    [Abstract] [Full Text] [Related]

  • 20. Bloodstream Trypanosoma cruzi parasites from mice simultaneously express antigens that are markers of acute and chronic human Chagas disease.
    Leguizamon MS, Campetella OE, Reyes MB, Ibañez CF, Basombrio MA, Rincon J, Orn A, Frasch AC.
    Parasitology; 1991 Jun 25; 102 Pt 3():379-85. PubMed ID: 1907729
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.